Cited by 319SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesComputational Drug Discovery Methods

High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.

Open access
Shen, Liang, Niu, Junwei, Wang, Chunhua, Huang, Baoying, Wang, Wenling, Zhu, Na, Deng, Yao, Wang, Huijuan +3 more·2019·Journal of Virology

Abstract

Currently, there is no approved therapy to treat coronavirus infection; therefore, broad-spectrum inhibitors of emerging and endemic CoVs are needed. Based on our high-throughput screening assay using a compound library, we identified seven compounds with broad-spectrum efficacy against the replication of four CoVs in vitro . Additionally, one compound (lycorine) was found to protect BALB/c mice against HCoV-OC43-induced lethality by decreasing viral load in the central nervous system. This inhibitor might offer promising therapeutic possibilities for combatting novel CoV infections in the future.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.00023-19

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 0.05-0.1% CPC showed potent, rapid activity against MERS-CoV and influenza viruses.

    “In addition, 0.05∼0.1% CPC showed potent, rapid activity against MERS-CoV (Shen et al., 2019) and influenza viruses (Popkin et al., 2017), however it’s activity against SARS-CoV-2 is currently unknown.”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Shen et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 66 · Cited by 319

Authors
Shen, L., Niu, J., Wang, C., Huang, B., Wang, W., Zhu, N., Deng, Y., Wang, H., Ye, F., Cen, S., & Tan, W.
Affiliations
  • Chinese Center For Disease Control and Prevention (CN)
  • National Institutes for Food and Drug Control (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Corresponding author
Tan, Wenjie
Venue
Journal of Virology
Published
2019-06-15
Volume
93
Issue
12
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2924519734
Cited by
319
References
66
Citations by year
2026: 12 · 2025: 15 · 2024: 19 · 2023: 32 · 2022: 63 · 2021: 85 · 2020: 88 · 2019: 3 · 2015: 1
FWCI
45.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Megaproject for Infectious Disease Research of China (2016ZX10004001-003)
  • National Key Research and Development Program of China (2016YFD0500300, 2016YFC1200200)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
coronavirus, high-throughput screening, lycorine, HCoV-OC43, viral replication inhibition, antiviral drug discovery
MeSH terms
Animals, Antiviral Agents, Cell Line, Drug Evaluation, Preclinical, Emetine, Humans, Mice, Inbred BALB C, Phenanthridines, Coronavirus, Coronavirus OC43, Human, Severe acute respiratory syndrome-related coronavirus, Amaryllidaceae Alkaloids, Mice, High-Throughput Screening Assays, Middle East Respiratory Syndrome Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review